PreveCeutical Medical (TSE:PREV) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
PreveCeutical Medical’s subsidiary, BioGene Therapeutics, appoints Dr. Linnea Olofsson as Chief Scientific Officer and Dr. Harry Parekh as Chief Research Officer to advance its drug and gene delivery technologies. These strategic appointments are expected to drive innovation and growth in the life sciences sector, positioning the company for future success.
For further insights into TSE:PREV stock, check out TipRanks’ Stock Analysis page.
